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http://dx.doi.org/10.1016/j.fjs.2013.Summary Background: Tuberculosis (TB) remains a prevalent infectious disease in eastern
Taiwan, and, tuberculous spondylitis has a great impact on the quality of daily life.
Aim: To investigate the demographics, clinical manifestation and treatment in eastern Taiwan.
Methods: From January 1988 to December 2010, the medical records were retrospectively re-
viewed of adult patients with a diagnosis of TB of the spine. Patients were enrolled with pos-
itive acid fast stain, culture results, or characteristic pathologic findings. Demographic data,
clinical manifestations, and the treatments were analyzed.
Results: During the period, 39 patients (24 women and 15 men) with TB of the spine were iden-
tified; the mean age was 54 years. The lumbar spine (26 patients, 63%) was the most commonly
involved site, followed by the thoracic spine (20 patients, 49%). The TB spine mostly involved
two vertebral segments, as noticed in 21 (51%) patients with spinal TB. There were six patients
(15%) with at least five segments involved. Concomitant pulmonary TB was found in sevenclare that they have no financial or non-financial conflicts of interest related to the subject matter or
.
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190 Y.-H. Chen et al.patients. Most patients received surgical correction plus a combination of anti-TB drugs (isoni-
azid, rifampin, ethambutol, pyrazinamide), and seven patients received medical treatment
only because of high surgical risk. Most commonly, surgery was performed with a combination
of anterior and posterior approaches. Most patients recovered well after surgery.
Conclusion: Patients with TB of the spine may involve more than one spinal segment. On the
basis of the four-drug combination in the initial phase followed by treatment for up to 12
months, along with appropriate surgical correction, can lead to good clinical outcomes with
acceptable risks.
Copyright ª 2013, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.Table 1 Demographic data in TB spine.
Characteristics Value
Age (y) 54 (18e86)
Age distribution
<65 24 (62%)
65 15 (38%)
Sex, M/F 28/11
Symptoms
Back pain 30 (77%)
Fever 3 (8%)
Limb weakness or numbness 13 (33%)
Complete paralysis 6 (15%)
Incontinence 3 (8%)
Comorbidities
Diabetes 4 (10%)
Chronic renal failure 3 (8%)
Liver cirrhosis 4 (10%)
Pulmonary tuberculosis 7 (18%)
Chronic obstructive pulmonary disease 1 (3%)
Drug abuser 1 (3%)1. Introduction
Tuberculosis (TB) remains a leading cause of death among
infectious diseases, and there is an estimation of over 3
million deaths in the world annually.1 The World Health
Organization estimates the global incidence of tuberculosis
to be at 9 million new cases/year, and 1e2% of these TB
patients to have spinal vertebral involvement.2e4 Although
there are well-established chemotherapeutic agents
against TB, the complications after TB of the spine, such as
syringomyelia, permanent neurological deficits, and spinal
osseous defects, sometimes remain unresolved after erad-
ication of pathogens. Therefore, surgical approaches are
indicated for TB of the spine to minimize the devastating
complications. In Taiwan, the estimated TB burden was 44/
million population/year in 2009, and the incidence in
eastern Taiwan, including Hualien and Taitung counties,
was almost twice as high as in west Taiwan.5 The mortality
was almost three times higher in east Taiwan than in the
overall Taiwan population.5 However, there have been few
studies in the treatments for TB of the spine in east Taiwan,
especially those investigating the surgical approaches for
those post-infectious complications. Hence, we conducted
this study to investigate the results of treatments for TB
spine.
2. Methods
Cases of spinal TB were retrospectively identified by
examining the medical records of patients admitted to
Buddhist Tzu-Chi General Hospital, Hualien, Taiwan, with
the diagnosis of spinal, TB from January 1988 to December
2010. This study was approved by the Institutional Review
Board and Ethics Committee of Buddhist Tzu-Chi General
Hospital. All patients were adult (age  18 years) and
diagnosed to have spinal TB by one of the following ex-
aminations: positive vertebral osseous acid fast stain; TB
culture data from vertebral specimen; or characteristic
pathologic finding. Data from 39 patients were examined.
Information retrieved included age, sex, comorbidities,
symptoms, number, and type of vertebral segments
involved, other complications (including disc involvement,
paraspinal abscess, and epidural abscess) and treatment
modalities (especially surgical modalities). Motor and sen-
sory impairments were classified according to the American
Spinal Injury Association (ASIA) impairment scale. The
neurologic response to therapy was classified as improve-
ment or worsening according to clinical presentation of thepatient. Treatment outcomes were classified as treatment
success, treatment failure, defaulted (poor medical
compliance), transfer out, and death. Data were analyzed
by SPSS for Windows version 17.0. (SPSS Inc., Chicago,
IL, USA).
3. Results
3.1. Patient demographics
Medical records of 39 patients were reviewed; 28 (72%)
were male and 11 (28%) female. The mean  standard
deviation age was 54  19 years (range, 18e86 years).
There were 24 (62%) patients older than 65 years (Table 1).
The age distribution of the patient group was bimodal with
the first peak at the 4th decade and another at the 7th
decade (Fig. 1).
3.2. Clinical presentation
Thirty (77%) patients complained of back pain, which was
the most common presenting symptom (Table 1). Limb
weakness and numbness were reported in 13 (33%) patients.
Six (15%) patients had severe motor deficit to complete
Figure 1 Distribution of patients according to age groups.
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including urinary or fecal incontinence was noted in three
(8%) patients. Among the 39 patients, only three (8%) had
fever. Twenty-two patients had no specific comorbidities
and 17 had comorbidities (Table 1). Four (10%) patients had
diabetes, three (8%) had chronic renal failure and four
(10%) had liver cirrhosis. One patient had chronic obstruc-
tive pulmonary disease and another was a drug abuser.
Seven patients had concomitant pulmonary TB.
3.3. Vertebral involvement
The number and location of vertebrae involved by TB were
documented by reviewing the image modalities and the
medical records describing intraoperative findings. The TB
spine mostly involved two vertebral segments, as noted in
21 (51%) patients. The total number of vertebra involved in
the remaining patient was as follows: one vertebra involved
in five (12%) patients, two vertebrae involved in 21 (51%)
patients, three vertebrae involved in five (12%) patients,Table 2 Data on involved spinal segments in TB spine.
N (%)
Location
Cervical 3 (7)
Thoracic 20 (49)
Lumbar 26 (63)
Sacral 3 (7)
Noncontiguous lesion 2 (5)
No. of vertebra involved
1 5 (12)
2 21 (51)
3 5 (12)
4 2 (5)
5 2 (5)
>5 4 (10)
Other complications
Disc involvement 15 (38)
Paraspinal abscess 13 (33)
Epidural abscess 8 (21)four vertebrae involved in two (5%) patients, five vertebrae
involved in two (5%) patients, and four (10%) patients had
more than five vertebral segments involved (Table 2).
The most commonly affected segment was the lumbar
vertebrae, in 26 patients, which accounted for 63% of all
cases, followed by thoracic vertebrae in 20 patients (49%),
and then cervical and sacral vertebrae, which both affected
three patients (7%). In addition, among the 39 TB spine pa-
tients, there were two patients with noncontiguous spinal
TB; one had disease invading the 4th thoracic vertebra and
the 3rde4th lumbar vertebrae. The other patient had skipped
lesions from the cervical, thoracic to lumbar vertebrae, and
a gibbus deformity over cervicothoracic junction.
In addition to the vertebral lesions, the other severe
complications are summarized in Table 2. There were 15
patients (38%) with discitis, 13 (33%) with paraspinal ab-
scess, and eight (21%) with epidural abscess.3.4. Treatments and clinical outcomes
Among the 39 patients diagnosed to have spinal TB, seven
received anti-TB chemotherapy only. The other 32 patients
(82%) received anti-TB drugs and surgery for debridement
or stabilization. The surgical approaches included the
anterior approach in nine patients (23%), posterior
approach in nine patients (23%), and both anterior and
posterior approach in 14 patients (36%). All patients treated
by surgery received decompression and most of the pa-
tients received fusion (23 patients) or instrumentation (18
patients) to stabilize the operated spine. All patients
received fusion by bone graft and none received cage fusion
(Table 3).
Medical record review for neurologic outcome assess-
ment was lost in three patients, who all received anti-TB
agents and surgery from both the anterior and posterior
approach. Of the other 36 patients, 25 (69%) had significant
clinical improvement and six patients (17%) complained of
persistent sensory or motor deficits. Among the six patients
with persistent neurological deficits, two had initial ASIA
scale B, two had initial ASIA scale C, one had initial ASIA
scale D, and one had initial ASIA scale E. The neurologic
outcomes and treatments modalities are summarized in
Table 4. With regard to the effects of medical treatment,
eight patients that had no confirmation in completion of
anti-TB agents were excluded. Of the remaining 31 pa-
tients, 24 (77%) had successful treatment, two (6%) patients
were transferred out, one (3%) had poor medical compli-
ance and four (13%) died, but not of TB. Two patients died
of infectious diseases, one had peritonitis from the tube of
peritoneal dialysis, one died of acute hepatitis from
Leptospirosis, one died of gastrointestinal hemorrhage, one
had end-stage renal disease and died of asystole due to
hyperkalemia (Table 5).
Most patients (50%) received medical treatment with a
four-drug combination (isoniazid þ rifampin þ ethambutol
þ pyrazinamide) in the first 2 months as intensive phase,
and the above combination without pyrazinamide in the
following 10 months as continuation phase. There were also
patients (14%) who received a short course of 6 months’
treatment with the four-drug combination in the first 2
months and the remaining course using the three-drug
Table 3 Treatment modalities for TB spine.
Treatments N (%)
Antibiotics only 7 (18)
Anterior approach 9 (23)
Drainage only 3
Bone graft 6
Cage 0
Anterior cervical plate 2
Posterior approach 9 (23)
Decompression only 6
Bone graft 3
Cage 0
Instrumentation 2
Both anterior and posterior 14 (36)
Bone graft 14
Cage 0
Instrumentation 14
Table 5 Outcomes after anti-TB drugs in 31 patients.a
Outcome N (%)
Treatment successb 24 (77.42)
Defaultc 1 (3.23)
Transfer out 2 (6.45)
Death 4 (12.90)
Treatment failure 0
a The other eight patients whose completion of anti-TB agents
was not confirmed were excluded.
b Treatment success at completion of anti-TB agents was
defined as clinical and radiological improvements.
c One patient showed poor medical compliance.
192 Y.-H. Chen et al.combination; some (36%) had 18 months’ treatment,
extending the continuation phase.
One of the patients successfully treated by surgery is
shown in Fig. 2. The patient initially presented with
noncontiguous spinal TB with a gibbus deformity at cervi-
cothoracic junction. After surgical correction, kyphotic
angle was corrected and the neurological function
improved from ASIA scale C to ASIA scale E. Another patient
was treated by anti-TB drugs only (Fig. 3). This patient
received anti-TB drugs for 18 months and the neurological
function improved from ASIA scale D to ASIA scale E.
4. Discussion
Spinal TB, also known as Pott’s disease, was first described
by Percival Pott in 1782.6 The disease results from infection
of spinal vertebra by hematologic spreading of the organism
of Mycobacterium tuberculosis. The organism is insidious
and stays in the skeletal system for a period prior to clinical
detection.7 After the clinical evident infection, the subse-
quent bony destruction and spinal nerve or cord compres-
sion can result in severe neurological deficits, such as
paraplegia or fecal incontinence. In contrast to the de-
mographic report of spinal TB from western Taiwan, inTable 4 Neurologic outcomes and treatment modalities.
Antibiotics
only (N Z 7) (%)
Surgery þ Antibiotics
(N Z 29) (%)a
Clinical
improvement
2 (29) 22 (76)
Persistent
neurological
deficit
3 (43) 3 (10)
Relapseb 1 (14) 1 (3)
Death 1 (14) 3 (10)
a There were a total of 32 patients undergoing surgery, and
three patients were lost to follow-up.
b One patient showed poor medical compliance and the other
had urinary relapse.which the affected patients were older (55% of patients
older than 70 years),8 our study revealed that 62% of all
patients were younger than 65 years. In addition, our age
distribution was bimodal, with the first peak at the 4th
decade and second peak at the 7th decade, and younger
patients were diagnosed to have spinal TB in eastern
Taiwan, whereas in most literature on TB spine de-
mographics, the age distribution was unimodal.8e11
Different sex predominance has been published without
definite conclusions,11e16 but our study showed a male
preponderance.
Spinal TB has a wide variety of manifestations, and the
infected spinal vertebra causes inflammation and insta-
bility, which initially constitutes axial pain. The most
common symptom in our patients was back pain (77%) and
systemic symptoms such as fever were seldom noticed (8%),
which were consistent with other reports.8,11,17e19 As the
inflammation proceeds, osseous destruction ensues and
more instability can cause deformity and compressing the
cord or spinal roots, subsequently causing neurological
deficits. In addition, overt infection and spreading through
weakened tissue can progress to abscess formation, which
can cause compression and neurological deficits as well. In
our study, the patients with complete paralysis (15%) and
fecal or urinary incontinence (8%) were much more
frequent than that in western Taiwan.8 This may be due to
the limited medical institutes in a large geographic area
and uneven distribution of medical hospitals in eastern
Taiwan. In addition to the neurological symptoms, our data
showed more vertebral segments involvement compared to
the report in western Taiwan.
The prevalence of medical comorbidity in our patient
group is not high; the possibility may be that most medical
comorbidities are noted in the elderly age group. Never-
theless, patients older than 65 years contributed only 38%
of the whole disease population, and thus, medical co-
morbidity might not be common in our study group.
Images are important for diagnosis and clinical decision
making in treating spinal TB, diagnostic role of various
imaging modalities have been discussed in previous litera-
ture.20,21 Magnetic resonance imaging (MRI) and spiral
computed tomography are most commonly used nowadays.
MRI has appreciable accuracy, and thus is favored in eval-
uation the neuronal damage in patients with spinal TB.22 In
addition, our two patients had noncontiguous spinal TB, as
similar prevalence reported from other studies.8,23 Kaila
et al had reported that with whole spinal MRI, the incidence
Figure 2 Sagittal reconstruction on spinal computed tomography demonstrating a kyphotic angle of (A) 61 prior to halo ring
traction, (B) 38.5 after traction, and (C) 36.5 28 months postoperatively.
Figure 3 Axial views on spinal computed tomography: (A) prior to anti-TB drugs, there was destruction of the L2 vertebral body
(arrow) and (B) 3 years after complete treatment, no significant demineralization of the L2 vertebral body was noted.
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71.4%.24 The prevalence of noncontiguous spinal TB in our
study can be even higher if all patients received whole
spinal MRI. Thus, whole spinal MRI for spinal TB needs to be
considered for possible multiple-level noncontiguous
lesions.
The rate of disc involvement in our study was 38%; an
even higher rate was published in a previous study.8 This
can be a conflict with our previous knowledge that M.
tuberculosis cannot cause disc destruction in comparison
with pyogenic spinal infection. Chang et al25 also reported
that spinal TB can cause discitis at a considerable rate, but
this is less prevalent and less severe compared with pyo-
genic spondylitis. The disease distribution in spinal verte-
bral bodies showed a thoracolumbar spine predominance,
in over half of all cases with spinal TB. Our disease distri-
bution was similar to that of other reports.8,10,26,27
Most of our patients received surgical managements plus
anti-TB drugs in spite of medical treatment only (82%), and
this percentage was analogous to that in western Taiwan
and slightly higher than that from France, and much higher
than that in Kenya (25.6%).8,10,27 In the available clinical
outcomes of our 36 patients, 29 patients received surgery
and most (76%) achieved clinical improvement; only 29% of
patients without surgery achieved neurological improve-
ment. Patients of TB spine who received surgery had a
better clinical outcome. In recent studies, the surgery of TB
spondylitis may improve quality of life and infection con-
trol, especially in patients infected by multidrug resistant
strands.28,29Pharmacologic therapy for treatment of spinal TB is
generally the same as for pulmonary TB. For patients
without previous pharmacologic therapy for TB, 6 months
of therapy with the four-drug combination (isoniazid,
rifampin, ethambutol, and pyrazinamide in first 2 months,
and above agents without pyrazinamide in the following 4
months) is sufficient. 30 Reports have demonstrated that a
6-month short-course treatment is not inferior to longer
treatment courses.31 In our patients, the treatment course
was from 9 months to 1 year, as mentioned in previous TB
treatment guidlines.32
Our study was limited by the enrolled cases and retro-
spective nature. This study may indicate the demographics
of spinal TB in eastern Taiwan and imply the importance of
surgical managements for spinal TB. In addition, this is the
first study investigating the demographics of spinal tuber-
culosis in eastern Taiwan and shows the difference from the
eastern Taiwan to western Taiwan. More attention needs to
be paid to spinal TB in eastern Taiwan.
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